Eli Lilly Chief Scientific Officer Dan Skovronsky spoke to CNBC about obesity pills and more on the future of weight loss.
About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, ...
A new case study is the latest to suggest that GLP-1 therapy can tamp down people's unhealthy cravings of drugs like alcohol ...
Swiss drugmaker Roche began a study last year of its experimental drug, RG6237, as a monotherapy in people with high body ...
Consumer Reports warns that there are important considerations, especially for older adults, before starting these treatments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results